🔎 Trials Near Me

Akèy › Atrofi Jeyografik › North Carolina

Etid klinik pou Atrofi Jeyografik nan North Carolina

7 etid pou Atrofi Jeyografik ap chèche patisipan nan sit nan North Carolina.

Vil nan North Carolina

Tèks ofisyèl etid la (Anglè)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Asheville Eye Associates - Western Carolina Retinal Associates, Asheville
  • Duke Eye Center, Durham
  • Graystone Eye, Hickory
  • ak 1 plis
Ap rekriteFaz 2/3
Laj 60 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06635148

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  • North Carolina (Nc) Retina Associates - Wake Forest Office- Site Number : 8400059, Wake Forest
Ap rekriteFaz 1/2
Laj 60 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07215234

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • NC Retina Associates, Cary
  • Graystone Eye, Hickory
  • North Carolina Retina Associates, Wake Forest
  • ak 1 plis
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • North Carolina Retina Associates, Cary
  • Duke Eye Center, Durham
  • North Carolina Retina Associates, Greenville
  • ak 1 plis
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06659445

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

  • Duke Eye Center, Durham
Ap rekriteEtid obsèvasyon
Laj 55 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07144137

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Western Carolina Retinal Associates, Asheville
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Dec 3, 2024 · NCT05438732

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.